United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read General business news Inside AIG’s bold specialty insurance play: Why the Convex‑Onex partnership could reshape underwriting and returns Discover how AIG and Onex are reshaping specialty insurance through a $7 billion Convex deal and $2B fund commitment. Learn what it means for the sector. byVenkateshOctober 31, 2025